Community/Retail

Avella to Distribute Tagrisso

By

Avella Specialty Pharmacy has announced that it will distribute Tagrisso, a new FDA-approved therapy for patients with non-small cell lung cancer with a specific type of gene mutation.

With more than 6 million pregnancies in the United States each year, health care providers require accurate and up-to-date information on the risks associated with prescribing medications to pregnant patients and breastfeeding infants.